Gibbs Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
12,506
+7,447
+147% +$860K 0.2% 108
2025
Q4
$559K Sell
5,059
-1,037
-17% -$97.3K 0.14% 180
2025
Q3
$512K Sell
6,096
-248
-4% -$20.4K 0.12% 209
2025
Q2
$502K Buy
6,344
+747
+13% +$59.4K 0.1% 224
2025
Q1
$502K Buy
5,597
+793
+17% +$74K 0.12% 188
2024
Q4
$478K Buy
4,804
+1,334
+38% +$138K 0.13% 175
2024
Q3
$394K Buy
3,470
+1,176
+51% +$140K 0.13% 180
2024
Q2
$284K Buy
2,294
+609
+36% +$78.4K 0.11% 190
2024
Q1
$222K Buy
+1,685
New +$208K 0.13% 174

Other funds holding MRK

Gibbs Wealth Management's MRK Position: Q1 2026 in Review

Gibbs Wealth Management increased its Merck (MRK) stake by 147% in Q1 2026, buying an estimated $860K and bringing the position to 12,506 shares worth $1.5M. The position accounts for 0.2% of the portfolio, ranked #108.

Gibbs Wealth Management first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,810 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gibbs Wealth Management held 12,506 shares of Merck worth $1.5M as of Q1 2026.
  • Gibbs Wealth Management bought 7,447 Merck shares in Q1 2026, an estimated $860K.
  • Merck made up 0.2% of Gibbs Wealth Management's portfolio in Q1 2026, its #108 holding.
  • Gibbs Wealth Management first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,810 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.